These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 20371357

  • 1. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase.
    Newton M, Niewczas I, Clark J, Bellamy TC.
    Anal Biochem; 2010 Jul 15; 402(2):129-36. PubMed ID: 20371357
    [Abstract] [Full Text] [Related]

  • 2. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
    Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F.
    Nitric Oxide; 2010 Jan 01; 22(1):43-50. PubMed ID: 19948239
    [Abstract] [Full Text] [Related]

  • 3. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC, Leiria LO, Silva FH, Mendes-Silvério CB, Calmasini FB, Davel AP, Mónica FZ, De Nucci G, Antunes E.
    J Pharmacol Exp Ther; 2014 Apr 01; 349(1):2-9. PubMed ID: 24421320
    [Abstract] [Full Text] [Related]

  • 4. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
    Toque HA, Antunes E, Teixeira CE, De Nucci G.
    Urology; 2008 Sep 01; 72(3):711-5. PubMed ID: 18359064
    [Abstract] [Full Text] [Related]

  • 5. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
    El-Sehemy A, Chang AC, Azad AK, Gupta N, Xu Z, Steed H, Karsan A, Fu Y.
    Cell Signal; 2013 Dec 01; 25(12):2780-7. PubMed ID: 24041655
    [Abstract] [Full Text] [Related]

  • 6. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1.
    Dove S, Danker KY, Stasch JP, Kaever V, Seifert R.
    Mol Pharmacol; 2014 Apr 01; 85(4):598-607. PubMed ID: 24470063
    [Abstract] [Full Text] [Related]

  • 7. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
    Nakane M, Kolasa T, Chang R, Miller LN, Moreland RB, Brioni JD.
    J Pharmacol Sci; 2006 Oct 01; 102(2):231-8. PubMed ID: 17050951
    [Abstract] [Full Text] [Related]

  • 8. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells.
    Borges de Oliveira-Junior E, Thomazzi SM, Rehder J, Antunes E, Condino-Neto A.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):43-9. PubMed ID: 17499238
    [Abstract] [Full Text] [Related]

  • 9. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.
    Bähre H, Danker KY, Stasch JP, Kaever V, Seifert R.
    Biochem Biophys Res Commun; 2014 Jan 24; 443(4):1195-9. PubMed ID: 24380860
    [Abstract] [Full Text] [Related]

  • 10. Efficient expression of human soluble guanylate cyclase in Escherichia coli and its signaling-related interaction with nitric oxide.
    Zhong F, Wang H, Ying T, Huang ZX, Tan X.
    Amino Acids; 2010 Jul 24; 39(2):399-408. PubMed ID: 20063108
    [Abstract] [Full Text] [Related]

  • 11. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER, Marletta MA.
    Annu Rev Biochem; 2012 Jul 24; 81():533-59. PubMed ID: 22404633
    [Abstract] [Full Text] [Related]

  • 12. The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.
    Bellamy TC, Garthwaite J.
    Mol Cell Biochem; 2002 Jan 24; 230(1-2):165-76. PubMed ID: 11952092
    [Abstract] [Full Text] [Related]

  • 13. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb 24; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

  • 14. Measurement of cGMP and soluble guanylyl cyclase activity.
    Southam E.
    Curr Protoc Toxicol; 2001 May 24; Chapter 10():Unit 10.5. PubMed ID: 23045027
    [Abstract] [Full Text] [Related]

  • 15. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP.
    Br J Pharmacol; 2009 Jul 24; 157(5):781-95. PubMed ID: 19466990
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
    Murthy KS.
    J Pharmacol Exp Ther; 2008 Apr 24; 325(1):183-9. PubMed ID: 18180373
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A, Hirth-Dietrich C, Alonso-Alija C, Härter M, Hahn M, Keim Y, Wunder F, Stasch JP.
    Arzneimittelforschung; 2008 Apr 24; 58(2):71-80. PubMed ID: 18412020
    [Abstract] [Full Text] [Related]

  • 18. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
    Vanneste G, Dhaese I, Sips P, Buys E, Brouckaert P, Lefebvre RA.
    J Physiol; 2007 Nov 01; 584(Pt 3):907-20. PubMed ID: 17717014
    [Abstract] [Full Text] [Related]

  • 19. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.
    Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R.
    Biochemistry; 2012 Jan 10; 51(1):194-204. PubMed ID: 22122229
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
    Pearce WJ, Williams JM, White CR, Lincoln TM.
    J Appl Physiol (1985); 2009 Jul 10; 107(1):192-9. PubMed ID: 19407253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.